Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin P Cusack

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|July 3, 2010
S1P(1) receptor agonists: Assessment of selectivity and current clinical activityKevin P Cusack, Robert H Stoffel
Bioorganic & Medicinal Chemistry Letters|March 19, 2015
Design strategies to address kinetics of drug binding and residence timeKevin P Cusack, Ying Wang, Michael Z Hoemann, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Emerging technologies for metabolite generation and structural diversificationKevin P Cusack, Hannes F Koolman, Udo E W Lange, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
A 13C NMR approach to categorizing potential limitations of alpha,beta-unsaturated carbonyl systems in drug-like moleculesKevin P Cusack, Lee D Arnold, Claude E Barberis, et al.
The Journal of Organic Chemistry|June 4, 2009
Scalable synthesis and isolation of the four stereoisomers of methyl 1-amino-3-(4-bromophenyl)cyclopentanecarboxylate, useful intermediates for the synthesis of S1P1 receptor agonistsGrier A Wallace, Thomas D Gordon, Martin E Hayes, et al.
Journal of Medicinal Chemistry|November 28, 2023
Free Energy Perturbation Approach for Accurate Crystalline Aqueous Solubility PredictionsRichard S Hong, Ana V Rojas, Rajni Miglani Bhardwaj, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2019
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonistsJérôme Amaudrut, Maria A Argiriadi, Martine Barth, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|July 3, 2010
S1P(1) receptor agonists: Assessment of selectivity and current clinical activityKevin P Cusack, Robert H Stoffel
Bioorganic & Medicinal Chemistry Letters|March 19, 2015
Design strategies to address kinetics of drug binding and residence timeKevin P Cusack, Ying Wang, Michael Z Hoemann, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Emerging technologies for metabolite generation and structural diversificationKevin P Cusack, Hannes F Koolman, Udo E W Lange, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
A 13C NMR approach to categorizing potential limitations of alpha,beta-unsaturated carbonyl systems in drug-like moleculesKevin P Cusack, Lee D Arnold, Claude E Barberis, et al.
The Journal of Organic Chemistry|June 4, 2009
Scalable synthesis and isolation of the four stereoisomers of methyl 1-amino-3-(4-bromophenyl)cyclopentanecarboxylate, useful intermediates for the synthesis of S1P1 receptor agonistsGrier A Wallace, Thomas D Gordon, Martin E Hayes, et al.
Journal of Medicinal Chemistry|November 28, 2023
Free Energy Perturbation Approach for Accurate Crystalline Aqueous Solubility PredictionsRichard S Hong, Ana V Rojas, Rajni Miglani Bhardwaj, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2019
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonistsJérôme Amaudrut, Maria A Argiriadi, Martine Barth, et al.
Pageof 1